HEALTH CATALYST INC's ticker is HCAT and the CUSIP is 42225T107. A total of 168 filers reported holding HEALTH CATALYST INC in Q4 2023. The put-call ratio across all filers is 0.13 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $101,818 | -39.6% | 15,934 | +10.2% | 0.00% | – |
Q1 2024 | $168,678 | +14.3% | 14,454 | -9.3% | 0.00% | – |
Q4 2023 | $147,549 | -8.5% | 15,934 | 0.0% | 0.00% | – |
Q3 2023 | $161,252 | -18.6% | 15,934 | +0.6% | 0.00% | – |
Q2 2023 | $198,050 | +17.4% | 15,844 | +9.6% | 0.00% | – |
Q1 2023 | $168,678 | +9.8% | 14,454 | 0.0% | 0.00% | – |
Q4 2022 | $153,646 | +12.2% | 14,454 | +2.3% | 0.00% | – |
Q3 2022 | $137,000 | -33.2% | 14,134 | 0.0% | 0.00% | – |
Q2 2022 | $205,000 | -44.0% | 14,134 | +0.8% | 0.00% | -100.0% |
Q1 2022 | $366,000 | -34.2% | 14,024 | 0.0% | 0.00% | 0.0% |
Q4 2021 | $556,000 | -17.8% | 14,024 | +3.7% | 0.00% | 0.0% |
Q3 2021 | $676,000 | -6.6% | 13,525 | +3.7% | 0.00% | 0.0% |
Q2 2021 | $724,000 | +57.0% | 13,045 | +32.3% | 0.00% | 0.0% |
Q1 2021 | $461,000 | +16.1% | 9,860 | +8.2% | 0.00% | 0.0% |
Q4 2020 | $397,000 | +19.2% | 9,110 | 0.0% | 0.00% | 0.0% |
Q3 2020 | $333,000 | +35.9% | 9,110 | +8.6% | 0.00% | 0.0% |
Q2 2020 | $245,000 | – | 8,390 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Daventry Group, LP | 2,247,053 | $14,358,669 | 6.41% |
First Light Asset Management, LLC | 3,956,089 | $25,279,409 | 2.22% |
Nepsis Inc. | 1,253,080 | $8,007,181 | 2.16% |
Granahan Investment Management | 1,042,733 | $6,663,064 | 0.27% |
Invenomic Capital Management LP | 850,581 | $5,435,213 | 0.26% |
PIER 88 INVESTMENT PARTNERS LLC | 130,240 | $832,234 | 0.19% |
ClariVest Asset Management LLC | 285,627 | $1,825,156 | 0.19% |
KENNEDY CAPITAL MANAGEMENT LLC | 1,274,844 | $8,146,253 | 0.17% |
CVS HEALTH Corp | 32,273 | $206,221 | 0.10% |
Olympiad Research LP | 18,987 | $121,327 | 0.09% |